Albert Labs International (FRA:VB50) Net Income (Continuing Operations): €-1.60 Mil (TTM As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Albert Labs International Net Income (Continuing Operations)?

Albert Labs International FRA:VB50 Net Income (Continuing Operations) is €-1.60 Mil as of Sep. 2023.

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Albert Labs International's Net Income (Continuing Operations) for the three months ended in Sep. 2023 was €-0.01 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2023 was €-1.60 Mil.

Albert Labs International  (FRA:VB50) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Albert Labs International Net Income (Continuing Operations) Related Terms

Albert Labs International Net Income (Continuing Operations) Historical Data

* Premium members only.

The historical data trend for Albert Labs International's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Albert Labs International Net Income (Continuing Operations) Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Net Income (Continuing Operations)
-1.30 -4.91

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.41 -1.21 -0.26 -0.11 -0.01

Albert Labs International Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income (Continuing Operations) of €-1.60 Mil mean?
Albert Labs International (FRA:VB50) has a Net Income (Continuing Operations) of €-1.60 Mil as of Sep. 2023. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Albert Labs International and its competitors.
Is Albert Labs International's Net Income (Continuing Operations) too high?
Albert Labs International's current Net Income (Continuing Operations) is €-1.60 Mil.
How does Albert Labs International's Net Income (Continuing Operations) compare to VRTX and REGN?
Albert Labs International's Net Income (Continuing Operations) of €-1.60 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income (Continuing Operations) for a Biotechnology company?
A good Net Income (Continuing Operations) depends on the Biotechnology industry context. However, Net Income (Continuing Operations) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income (Continuing Operations) mean?
A high Net Income (Continuing Operations) can signal that a stock is expensive relative to its fundamentals. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Albert Labs International and its competitors. Albert Labs International's current Net Income (Continuing Operations) is €-1.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Albert Labs International stock overvalued right now?
Albert Labs International (FRA:VB50) has a current Net Income (Continuing Operations) of €-1.60 Mil. The current Net Income (Continuing Operations) is €-1.60 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income (Continuing Operations) calculated?
Net Income (Continuing Operations) is calculated from a company's financial statements. For Albert Labs International (FRA:VB50), the current Net Income (Continuing Operations) is €-1.60 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Albert Labs International Business Description

Address 201-6996 Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research, and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of a clinical pathway.